BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9717118)

  • 21. The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization.
    Orvieto R; Zohav E; Scharf S; Rabinson J; Meltcer S; Anteby EY; Homburg R
    Gynecol Endocrinol; 2007 Feb; 23(2):72-5. PubMed ID: 17454155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low dose clomiphene citrate as a mild stimulation protocol in women with unsuspected poor in vitro fertilization result can generate more oocytes with optimal cumulative pregnancy rate.
    Ochin H; Ma X; Wang L; Li X; Song J; Meng Y; Shen J; Cui YG; Liu J
    J Ovarian Res; 2018 May; 11(1):37. PubMed ID: 29728130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High dosages of gonadotropins are associated with poor pregnancy outcomes after in vitro fertilization-embryo transfer.
    Stadtmauer L; Ditkoff EC; Session D; Kelly A
    Fertil Steril; 1994 Jun; 61(6):1058-64. PubMed ID: 8194617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relation between the outcome of IVF-ET and subtle rise in serum progesterone during the follicular phase stimulated with a combination of gonadotropin-releasing hormone analog and gonadotropin].
    Sekijima A
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Mar; 45(3):249-55. PubMed ID: 8492012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supraphysiologic estradiol is an independent predictor of low birth weight in full-term singletons born after fresh embryo transfer.
    Pereira N; Elias RT; Christos PJ; Petrini AC; Hancock K; Lekovich JP; Rosenwaks Z
    Hum Reprod; 2017 Jul; 32(7):1410-1417. PubMed ID: 28505290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian endometriomas do not adversely affect pregnancy success following treatment with in vitro fertilization.
    Isaacs JD; Hines RS; Sopelak VM; Cowan BD
    J Assist Reprod Genet; 1997 Nov; 14(10):551-3. PubMed ID: 9447452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproducibility and clinical significance of pre-ovulatory serum progesterone level and progesterone/estradiol ratio on the day of human chorionic gonadotropin administration in infertile women undergoing repeated in vitro fertilization cycles.
    Lin YJ; Lan KC; Huang FJ; Lin PY; Chiang HJ; Kung FT
    Reprod Biol Endocrinol; 2015 May; 13():41. PubMed ID: 25967104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cumulative dose of gonadotropins used for controlled ovarian stimulation does not influence the odds of embryonic aneuploidy in patients with normal ovarian response.
    Sekhon L; Shaia K; Santistevan A; Cohn KH; Lee JA; Beim PY; Copperman AB
    J Assist Reprod Genet; 2017 Jun; 34(6):749-758. PubMed ID: 28321529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
    Zhu RR; Xiao SQ; Zhao JZ; Lin J; Wang PY; Jin CC; Jin WM
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing the stimulation dose of rFHS in unexpected poor responders is not associated with better IVF outcome.
    Tutuncu L; Dundar O
    Ginekol Pol; 2012 Feb; 83(2):111-5. PubMed ID: 22568355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of supraphysiologic estradiol levels on human nidation.
    Gelety TJ; Buyalos RP
    J Assist Reprod Genet; 1995 Aug; 12(7):406-12. PubMed ID: 8574066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian response to gonadotropins in patients with tubal factor infertility: salpingectomy versus nonsalpingectomy.
    Lin YJ; Ou YC; Huang FJ; Lin PY; Kung FT; Lan KC
    J Minim Invasive Gynecol; 2013; 20(5):637-41. PubMed ID: 23706676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Methotrexate or Salpingectomy for Ectopic Pregnancy on Subsequent In Vitro Fertilization-Embryo Transfer Outcomes.
    Pereira N; Gerber D; Gerber RS; Lekovich JP; Elias RT; Spandorfer SD; Rosenwaks Z
    J Minim Invasive Gynecol; 2015; 22(5):870-6. PubMed ID: 25917279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience.
    Cardozo ER; Thomson AP; Karmon AE; Dickinson KA; Wright DL; Sabatini ME
    J Assist Reprod Genet; 2015 Apr; 32(4):587-96. PubMed ID: 25595540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of antagonist mild and long agonist protocols in terms of follicular fluid total antioxidant capacity.
    Aydogan Mathyk B; Aslan Cetin B; Vardagli D; Zengin E; Sofiyeva N; Irez T; Ocal P
    Taiwan J Obstet Gynecol; 2018 Apr; 57(2):194-199. PubMed ID: 29673660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Do poor-responder patients benefit from increasing the daily gonadotropin dose from 300 to 450 IU during controlled ovarian hyperstimulation for IVF?].
    Haas J; Zilberberg E; Kedem A; Dar S; Orvieto R
    Harefuah; 2015 Feb; 154(2):114-7, 135. PubMed ID: 25856865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian response to gonadotropin stimulation in repeated IVF cycles after unilateral salpingectomy.
    Tal J; Paltieli Y; Korobotchka R; Ziskind G; Eibschitz I; Ohel G
    J Assist Reprod Genet; 2002 Oct; 19(10):451-5. PubMed ID: 12416648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
    Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
    Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.